Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

3.17
Delayed Data
As of Aug 28
 +0.12 / +3.93%
Today’s Change
2.55
Today|||52-Week Range
4.35
+4.28%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close3.05
Today’s open3.07
Day’s range2.96 - 3.23
Volume86,518
Average volume (3 months)46,723
Market cap$75.4M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+67.91%
Earnings growth (this year)+64.13%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+151,457.89%
P/E ratioNM
Price/Sales1.23
Price/Book--

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...+0.09+2.67%
MSTXMast Therapeutics In...+0.02+3.96%
IMMYImprimis Pharmaceuti...0.000.00%
BOTABiota Pharmaceutical...0.000.00%
Data as of 4:00pm ET, 08/28/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$28.8M
Annual profit (last year)-$19.9M
Net profit margin-69.18%

Profile

Sector
Health Technology
Industry
Medical Specialties
President &
Chief Executive Officer
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers